TuHURA Biosciences
-
Ticker
HURA
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 11-50 Employees
- Based in Tampa, Florida
TuHURA Biosciences, Inc. is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The Company’s technologies are designed to overcome primary and acquired resistance to checkpoint inhibitors or cellular therapies in the treatment of cancer.
TuHURA Biosciences
Most Recent Annual Report
MOST RECENT
2024 Annual Report and Form 10K
Older/Archived Annual Reports